Results 41 to 50 of about 11,850 (208)

Criptococose cutânea causada por Cryptococcus gattii em um paciente sob corticoterapia crônica [PDF]

open access: yes, 2010
Cryptococcus gattii é agente causador de uma micose endêmica que afeta principalmente os pulmões e o sistema nervoso central de pacientes imunocompetentes em regiões tropicais e subtropicais do globo. Relato de caso.
BACIOTTI, Maysa   +5 more
core   +2 more sources

Characteristics of pulmonary cryptococcosis in patients with rheumatoid arthritis

open access: yesBMJ Open Respiratory Research, 2021
Background and objective A high frequency of infections complicating rheumatoid arthritis (RA) has been reported due to the immunomodulatory effect of RA or to agents with immunosuppressive effects used in its treatment.
Ryuji Uozumi   +5 more
doaj   +1 more source

Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review.

open access: yes, 2012
OBJECTIVES: Given the imperative to scale up integrated tuberculosis (TB) and HIV services in settings where both are of major public health importance, we aimed to synthesise knowledge concerning implementation of TB/HIV service integration.
Atun   +36 more
core   +1 more source

End-stage liver disease Is a strong predictor of early mortality in cryptococcosis [PDF]

open access: yes, 2015
Background. Cryptococcosis in the setting of end-stage liver disease (ESLD) has been associated with high mortality. We sought to compare the outcome of cryptococcal disease in patients with ESLD to that of human immunodeficiency virus (HIV)-positive ...
Powderly, William G   +2 more
core   +2 more sources

Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children [PDF]

open access: yes, 2017
AW and JK are supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of AberdeenPeer reviewedPublisher ...
King, Jill   +4 more
core   +1 more source

Identification of risk factors for disseminated cryptococcosis in non-hiv patients: a retrospective analysis

open access: yesEuropean Journal of Medical Research, 2023
Objective This study aimed to investigate the potential risk factors associated with disseminated cryptococcosis in HIV-negative individuals. Methods A total of 106 HIV-negative patients with cryptococcal disease were enrolled.
Fan Zhang   +3 more
doaj   +1 more source

Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006 [PDF]

open access: yes, 2009
Deaths caused by systemic mycoses such as paracoccidioidomycosis, cryptococcosis, histoplasmosis, candidiasis, aspergillosis, coccidioidomycosis and zygomycosis amounted to 3,583 between 1996-2006 in Brazil. When analysed as the underlying cause of death,
LAURENTI, Ruy   +4 more
core   +3 more sources

Infection control in the brain and the eye

open access: yesActa Ophthalmologica, EarlyView.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester   +2 more
wiley   +1 more source

Chronic disseminated cryptococcosis without meningeal involvement in a severely immunosuppressed HIV-infected patient successfully treated with fluconazole

open access: yesMedical Mycology Case Reports, 2022
A 43-year-old female with advanced HIV infection presented with two chronic skin lesions. Cutaneous cryptococcosis was confirmed and pulmonary cryptococcosis was suspected.
Tatiane da Silveira Yonekura   +3 more
doaj   +1 more source

Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis [PDF]

open access: yes, 2018
The diagnosis of central nervous system (CNS) histoplasmosis is often difficult. Although cerebrospinal fluid (CSF) (1,3)-β-d-glucan (BDG) is available as a biological marker for the diagnosis of fungal meningitis, there are limited data on its use for ...
Albers, Amanda   +12 more
core   +2 more sources

Home - About - Disclaimer - Privacy